Article Sidebar

Download
PDF (Bahasa Indonesia)
Statistic
Read Counter : 782 Download : 465

Downloads

Download data is not yet available.

Main Article Content

Abstract

Mental disorders are severe mental health problems that cause cognitive, affective and social functioning impairments. Diabetes mellitus is a disease with hyperglycemia. The use of diabetes mellitus drugs in psychiatric patients can pose a risk of potential interactions between drugs that will result in the possibility of irrational drug use. The purpose of this study was to evaluate the use of diabetes mellitus drugs in psychiatric patients at Sambang Lihum Mental Hospital. The method used is descriptive observational method with survey design and sampling technique, namely total sampling and retrospective data collection with appropriate assessment indicators are the 14 appropriate criteria from the Ministry of Health, so that the results obtained are the majority of gender is male as many as 15 people (55.56%) and the majority of age is 45-59 years as many as 16 people (59.26%). Evaluation of the use of single diabetes mellitus drugs as many as 9 people (33.33%) and a combination of 18 people (66.67%). Evaluation of the use of diabetes mellitus drugs was obtained by 26 rational people (96.30%) and 1 irrational person (3.70%) and all the use of diabetes mellitus drugs was in accordance with the hospital formulary and treatment guidelines. The conclusion of this study is that there is still irrational use of drugs in the criteria of patient adherence to treatment so that it has the potential to cause harm to the patient.

Keywords

Diabetes Mellitus Drug Used Evaluation Psychiatry

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Author Biographies

Rina Saputri, Program Studi Sarjana Farmasi, Fakultas Kesehatan Universitas Sari Mulia

Program Studi Sarjana Farmasi, Fakultas Kesehatan Universitas Sari Mulia

Eka Febrianti Maulani, Program Studi Sarjana Farmasi, Fakultas Kesehatan Universitas Sari Mulia

Program Studi Sarjana Farmasi, Fakultas Kesehatan Universitas Sari Mulia

Nur Hidayah, Program Studi Sarjana Farmasi, Fakultas Kesehatan Universitas Sari Mulia

Program Studi Sarjana Farmasi, Fakultas Kesehatan Universitas Sari Mulia

Saftia Aryzki , Program Studi Pendidikan Profesi Apoteker, Fakultas Kesehatan Universitas Sari Mulia

Program Studi Pendidikan Profesi Apoteker, Fakultas Kesehatan Universitas Sari Mulia
How to Cite
Saputri, R., Maulani, E. F., Hidayah, N., & Aryzki , S. (2025). EVALUASI PENGGUNAAN OBAT DIABETES MELLITUS PADA PASIEN PSIKIATRI DI RUMAH SAKIT JIWA SAMBANG LIHUM PERIODE 2022-2023. Borneo Journal of Pharmascientech, 9(1), 97-110. https://doi.org/10.59053/bjp.v9i1.634
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Abdulah, Afry Zaldy, Titik Suerni, and Etik Nurochmah. 2023. “Masalah Kesehatan Mental Generasi Z Di Rumah Sakit Jiwa.” Jurnal Keperawatan Jiwa (JKJ): Persatuan Perawat Nasional Indonesia 11(2): 267–72.
  2. Aulia Ramdini, Dwi, Lilik Koernia Wahidah, and Dwi Atika. 2021. “Evaluasi Rasionalitas Penggunaan Obat Diabetes Melitus Tipe Ii Pada Pasien Rawat Jalan Di Puskesmas Pasir Sakti Tahun 2019.” JFL: Jurnal Farmasi Lampung 9(1): 69–76.
  3. Ernst, E. 2001. “Drug Interactions. A Source Book of Adverse Interactions, Their Mechanisms, Clinical Importance and Management.” Focus on Alternative and Complementary Therapies 6(1): 49–49.
  4. Haerani. 2021. “Evaluasi Rasionalitas Penggunaan Obat Antihipertensi Pada Pasien Geriatri Di Instalasi Rawat Inap Rs Islam Siti Khadijah Kota.” 4(2): 134.
  5. Hidayat, Arief Nur, Tiara Ajeng L, and Kusumaningtyas Siwi. 2023. “EVALUASI RASIONALITAS OBAT ANTIDIABETES ORAL TERHADAP EFEKTIVITAS TERAPI PASIEN DIABETES MELITUS TIPE II RSUD Dr. MOEWARDI SURAKARTA.” Jambura Journal of Health Sciences and Research 5(3): 815–24.
  6. Kemenkes RI. 2011. “Modul Penggunaan Obat Rasional 2011.” Modul Penggunaan Obat Rasional: 3–4.
  7. Lestari. 2019. “Implementasi Metode Clark Dan Young Untuk Menentukan Dosis Obat Pada Anak-Anak.” Angewandte Chemie International Edition, 6(11), 951–952. 2(1): 100–108.
  8. Pratiwi, Deski, M Dody Izhar, and Muhammad Syukri. 2022. “Data Riskesdas 2018 Prevalence of Diabetes Mellitus and Its Associated Factors in Jambi Province : Secondary Data Analysis of Basic Health Survey 2018.” Jurnal Kesehatan Komunitas 8(1): 79–85.
  9. Riskesdas Kalsel. 2020. Laporan Riskesdas Nasional 2019 Laporan Provinsi Kalimantan Selatan RISEKDAS. https://ejournal2.litbang.kemkes.go.id/index.php/lpb/issue/view/253.
  10. Rohmatulloh, Vanda Rizky, Bambang Pardjianto, and Larasati Sekar Kinasih. 2024. “Terdapat 27 Orang (100%) Pasien Memenuhi Kriteria Tepat Adian Diabetes Melitus Tipe 2 Berdasarkan 4 Kriteria Diagnosis Di Poliklinik Penyakit.” 8(April): 2528–43.
  11. Siahaan, Maya Fernandya et al. 2023. “Risk Factors for Diabetes Mellitus in Men of Productive Age in India (National Family Health Survey2015-2016).” Jurnal Biometrika dan Kependudukan 12(1): 22–31.
  12. Sihombing, Aquila Graham Gibraltar Sihombing1. 2020. “Rasionalitas Pengobatan Diabetes Melitus Tipe II.” Jurnal Bagus 02(01): 402–6.
  13. Soelistijo, Soebagio. 2021. “Pedoman Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Dewasa Di Indonesia 2021.” Global Initiative for Asthma: 46. www.ginasthma.org.
  14. Syahputra, Edi et al. 2021. “Determinan Peningkatan Orang Dengan Gangguan Jiwa (Odgj) Di Kota Langsa the Determination of People Improvement With Mental Disorders (Odgj) in the City of Langsa.” Journal of Healthcare Technology and Medicine 7(2): 2615–109.
  15. Topan, Wisnu. 2019. “Implementasi Penjualan Obat Harga Eceran Tertinggi (HET) Dalam Rangka Perlindungan Konsumen Oleh Pelaku Usaha Apotek Dikota Pekanbaru.” JOM Fakultas Hukum VI(1): 1–23.